Dow Up 0.51% Nasdaq Up 0.24%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM
1.43 Up 0.02(1.42%) Nov 21, 4:00PM EST
|After Hours : 1.43 Up 0.00 (0.01%) Nov 21, 4:45PM EST
Prev Close:1.41
Open:1.43
Bid:1.22 x 100
Ask:N/A
1y Target Est:4.17
Beta:0.01
Earnings Date:Dec 8 - Dec 12 (Est.)
Day's Range:1.41 - 1.45
52wk Range:1.24 - 3.18
Volume:541,229
Avg Vol (3m):1,018,510
Market Cap:256.69M
P/E (ttm):N/A
EPS (ttm):-0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PPHM

Comparison

Symbol% ChgMkt Cap
PPHMUp 1.42%256.69M
AMGNUp 0.08%123.84B
NVSDown 0.30%229.73B
RHHBYDown 1.04%253.38B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Apr-15) :-0.30
Quarterly EPS Est (Oct-14) :-0.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the research and development of novel monoclonal antibodies for the treatment and diagnosis of cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback